Baush + Lomb names DACH chief
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Valeant Pharmaceuticals subsidiary Bausch + Lomb has appointed Petrik Dauer as general manager and commercial director for prescription and OTC operations at its Germany, Austria and Switzerland (DACH) division.